Polymer-peptide hybrids as a highly immunogenic single-dose nanovaccine

Nanomedicine (Lond). 2014 Jan;9(1):35-43. doi: 10.2217/nnm.13.7. Epub 2013 Apr 23.

Abstract

Aim: To explore four-arm star poly(t-butyl)acrylate (P(t)BA)-peptide and linear P(t)BA-peptide conjugates as a vaccine-delivery system against Group A Streptococcus.

Materials & methods: P(t)BA nanoparticles bearing J14 peptide epitopes were prepared via alkyne-azide 1,3-dipolar cycloaddition 'click' reaction. The conjugated products were self-assembled into small or large nanoparticles. These nanoparticle vaccine candidates were evaluated in vivo and J14-specific antibody titers were assessed.

Results & discussion: Mice vaccinated with the nanoparticles were able to produce J14-specific IgG antibodies without the use of an external adjuvant after a single immunization. We have demonstrated for the first time that the immune responses against self-assembled P(t)BA nanoparticles are stronger for the smaller sized (~20 nm) nanoparticles compared with the larger (~500 nm) P(t)BA nanoparticles.

Conclusion: PtBA analogs have the potential to be developed as potent carrier systems for single-dose synthetic vaccines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic
  • Animals
  • Drug Delivery Systems*
  • Epitopes / immunology
  • Humans
  • Immunoglobulin G / immunology
  • Mice
  • Nanomedicine
  • Nanoparticles / chemistry
  • Nanoparticles / therapeutic use
  • Peptides / chemistry
  • Peptides / immunology
  • Peptides / therapeutic use*
  • Polymers / chemistry
  • Polymers / therapeutic use*
  • Vaccines / immunology
  • Vaccines / therapeutic use*

Substances

  • Adjuvants, Immunologic
  • Epitopes
  • Immunoglobulin G
  • Peptides
  • Polymers
  • Vaccines